Fairer financing of vaccines in a world living with COVID-19.
;
Justice Nonvignon;
Richmond Owusu;
Kalipso Chalkidou;
Abigail Colson;
Mohamed Gad;
Petra Klepac ;
Francis Ruiz ;
Alec Morton;
(2020)
Fairer financing of vaccines in a world living with COVID-19.
BMJ GLOBAL HEALTH, 5 (7).
e002951-e002951.
ISSN 2059-7908
DOI: 10.1136/bmjgh-2020-002951
Summary box
The COVID-19 pandemic has disrupted routine and campaign-based vaccination, potentially increasing the future vaccine-preventable disease burden and threatening to overwhelm health systems.
Vaccine-preventable diseases are transboundary problems that require global cooperation to achieve the best outcomes.
Investments, predominantly by rich countries—in effect transfers to poor countries—are required as part of the financing solution. Theoretical advances show how such funds can be operationally prioritised and disbursed equitably. Such transfers are also in the interest of high-income countries, and cooperation achieves better outcomes than strategies such as travel restrictions for vaccine-preventable diseases.
Similar cooperation and financing issues will arise if and when it is time to distribute a COVID-19 vaccine.
-
picture_as_pdf - Fairer financing of vaccines in a world living with COVID-19.pdf
-
subject - Published Version
-
- Available under Creative Commons: 3.0